Clinimix 1242 mg (Alanine SOLUTION) 1242 MG

Clinimix 1242 mg is an intravenous solution containing alanine, designed to provide essential amino acids for nutritional support. This product is manufactured by Baxter Corporation in Canada and is suitable for patients requiring parenteral nutrition.

Strength

1242 MG

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clinimix 1242 mg is primarily used for nutritional support in patients who cannot absorb nutrients through the digestive system. This intravenous solution provides essential amino acids, including alanine, to help maintain proper nutrition and support overall health. It is often used in clinical settings where oral or enteral nutrition is not feasible.

Side Effects

The effects of Clinimix 1242 mg are primarily related to its role in providing essential amino acids. Patients may experience improved nutritional status and better overall health when used as directed. However, individual responses can vary, and it is important to follow medical guidance when using this product.

Precautions & Warnings

Clinimix 1242 mg should be administered under medical supervision. It is important to inform healthcare providers of any allergies or medical conditions before use. Proper handling and storage are crucial to maintain the integrity of the solution. Always follow the instructions provided by healthcare professionals.

Avoid Interactions

Clinimix 1242 mg may interact with other medications or supplements. It is important to discuss all current medications with a healthcare provider before starting this treatment. Additionally, interactions with certain medical conditions should be considered, and regular monitoring may be necessary.

Frequently Asked Questions

Clinimix 1242 mg is used for nutritional support in patients who cannot absorb nutrients through the digestive system.

Clinimix 1242 mg is administered intravenously under medical supervision.

Common effects include improved nutritional status and overall health, though individual responses can vary.

Yes, it should be administered under medical supervision, and proper handling and storage are crucial.

Yes, it may interact with other medications or supplements, so it is important to discuss all current medications with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.